12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·02/25/2026 17:05:39
Listen to the news
Gainers
Larimar Therapeutics (NASDAQ:LRMR) shares moved upwards by 58.4% to $5.84 during Wednesday's regular session. The company's market cap stands at $306.6 million.
Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock moved upwards by 26.13% to $4.17. The company's market cap stands at $6.0 million.
Acadia Healthcare Co (NASDAQ:ACHC) stock rose 23.99% to $21.29. The company's market cap stands at $1.5 billion. The company's, Q4 earnings came out today.
NovoCure (NASDAQ:NVCR) stock increased by 23.55% to $14.51. The company's market cap stands at $1.3 billion.
VolitionRX (AMEX:VNRX) shares increased by 20.6% to $0.23. The company's market cap stands at $26.2 million.
C4 Therapeutics (NASDAQ:CCCC) stock rose 18.84% to $2.84. The company's market cap stands at $222.4 million.
Losers
CASI Pharmaceuticals (NASDAQ:CASI) stock declined by 57.7% to $0.34 during Wednesday's regular session. The market value of their outstanding shares is at $12.3 million.
MannKind (NASDAQ:MNKD) shares fell 37.1% to $3.48. The company's market cap stands at $1.6 billion.
20/20 Biolabs (NASDAQ:AIDX) shares fell 30.83% to $5.52. The market value of their outstanding shares is at $82.5 million.
Geron (NASDAQ:GERN) stock fell 18.72% to $1.58. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q4 earnings came out today.
Ironwood Pharmaceuticals (NASDAQ:IRWD) shares fell 18.47% to $3.09. The market value of their outstanding shares is at $616.5 million. As per the news, the Q4 earnings report came out today.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.